furosemide has been researched along with Acute Lung Injury in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This review aims to examine all published studies concerning potential treatments for phosgene-induced acute lung injury and incorporate them into up-to-date clinical guidance." | 8.86 | Management of phosgene-induced acute lung injury. ( Grainge, C; Rice, P, 2010) |
| "Nebulised furosemide treatment following phosgene induced acute lung injury does not improve survival and worsens PaO2: FiO2 ratio." | 7.76 | Furosemide in the treatment of phosgene induced acute lung injury. ( Fairhall, SJ; Grainge, C; Jenner, J; Jugg, BJ; Mann, T; Millar, T; Perrott, R; Rice, P; Smith, AJ, 2010) |
| "This review aims to examine all published studies concerning potential treatments for phosgene-induced acute lung injury and incorporate them into up-to-date clinical guidance." | 4.86 | Management of phosgene-induced acute lung injury. ( Grainge, C; Rice, P, 2010) |
| "Nebulised furosemide treatment following phosgene induced acute lung injury does not improve survival and worsens PaO2: FiO2 ratio." | 3.76 | Furosemide in the treatment of phosgene induced acute lung injury. ( Fairhall, SJ; Grainge, C; Jenner, J; Jugg, BJ; Mann, T; Millar, T; Perrott, R; Rice, P; Smith, AJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grainge, C | 2 |
| Rice, P | 2 |
| Smith, AJ | 1 |
| Jugg, BJ | 1 |
| Fairhall, SJ | 1 |
| Mann, T | 1 |
| Perrott, R | 1 |
| Jenner, J | 1 |
| Millar, T | 1 |
| Grams, ME | 1 |
| Estrella, MM | 1 |
| Coresh, J | 1 |
| Brower, RG | 1 |
| Liu, KD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Agreement Test of Intravascular Volume Assessment Between Inferior Vena Cava (IVC) Diameter and Vascular Pedicle Width (VPW)[NCT03535038] | 35 participants (Actual) | Interventional | 2018-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for furosemide and Acute Lung Injury
| Article | Year |
|---|---|
Management of phosgene-induced acute lung injury.
Topics: Acetylcysteine; Acute Lung Injury; Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-S | 2010 |
2 other studies available for furosemide and Acute Lung Injury
| Article | Year |
|---|---|
Furosemide in the treatment of phosgene induced acute lung injury.
Topics: Acute Lung Injury; Administration, Inhalation; Animals; Disease Models, Animal; Female; Furosemide; | 2010 |
Fluid balance, diuretic use, and mortality in acute kidney injury.
Topics: Acute Kidney Injury; Acute Lung Injury; Critical Illness; Diuretics; Female; Fluid Therapy; Furosemi | 2011 |